News has found in which if nitroglycerin is given to women who are going to deliver premature baby, it will be beneficial for baby.
Led by Dr. Graeme Smith (Obstetrics and Gynaecology), the five-year, randomized controlled trial involved 153 women who were conscripted at the time they went into pre-term labour. The study was planned by the Queen’s Perinatal Research Unit at Kingston General Hospital, with data management by the Ottawa Maternal Neonatal Investigators at the Ottawa Health Research Institute.
According to the study nitroglycerin patches for pregnant women helps to extend pregnancy and — most prominently — improves babies’ outcome, with slight side effects than experienced through the use of other drugs.
Approximately 7.5 per cent of all babies born in Canada are born prematurely (before 37 weeks) and 1 to 2 per cent is born before 34 weeks. “It is this later group that is most concerning as these babies are at the highest risk of immediate and long-term medical complications,” says Dr. Smith, an expert in high-risk obstetrics.
“Dr. Smith’s trial results have provided us new information on one possible solution to reduce the adverse effects of pre-term labour,” said Dr. Michael Kramer, Scientific Director of the CIHR Institute of Human Development, Child and Youth Health. “This result is very promising and it provides reassurance for expecting mothers and their families.”
The team’s findings are highlighted as an “Editor’s Choice” in the January issue of the American Journal of Obstetrics and Gynecology. An editorial in the journal commends “the excellence of their clinical research” and “the study design, execution and report.”